Skip to main content

Table 4 Outcomes of the ELBW infants whose DA was closed after 2nd course COI vs. those whose DA remained patent after 2nd course

From: Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants

 

Closed (n = 42)

Not Closed (n = 37)

P

CLD

16 (38.1%)

25 (67.6%)

0.013

NEC

5 (11.9%)

3 (8.1%)

ns

IVH III-IV

3 (7.1%)

3 (8.1%)

ns

ROP

27 (64.3%)

24 (64.9%)

ns

Age at extubation, days

27 (6)

33 (5)

ns

Age at full feeds, days

33 (2)

34 (2)

ns

Age at discharge, days

101 (4)

109 (13)

ns